Colin Stott
Fortune : 173 850 $ au 31/05/2026
Fortune : 173 850 $ au 31/05/2026
Colin G.
Stott is the founder of Phytotherapeutix Holdings Ltd., founded in 2020, serving as Chief Executive Officer.
Mr. Stott is the founder of Phytotherapeutix Ltd., founded in 2019, serving as Chief Executive Officer.
Current jobs include Independent Director at Cardiol Therapeutics, Inc. since 2019 and Chief Operating Officer & Director at Alterola Biotech, Inc. since 2021.
Former jobs include Chief Operating Officer & Director at Alterola Biotech, Inc. (California), Director at Protagenic Therapeutics, Inc. in 2025, Director-Scientific Affairs at GW Pharmaceuticals Ltd. from 2017 to 2019, Manager-Clinical Projects at Phytopharm Plc in 1999, Manager-Clinical Programme at Napp Pharmaceuticals Ltd. in 1990, and Chief Operating Officer at Alinova Biosciences Ltd. from 2019 to 2020.
Education includes undergraduate studies at Loughborough University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/12/2025 | 142 500 ( 0,13 % ) | 173 850 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALTEROLA BIOTECH, INC. | Directeur des opérations | 21/06/2021 |
| CARDIOL THERAPEUTICS INC. | Directeur/Membre du Conseil | 03/12/2019 |
Phytotherapeutix Holdings Ltd. | Directeur Général | 01/11/2020 |
Phytotherapeutix Ltd. | Directeur Général | 01/04/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Directeur des opérations | 08/08/2025 |
Alinova Biosciences Ltd. | Directeur des opérations | 01/12/2020 |
| GW PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/05/2019 |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Engages in developing novel treatments targeting diseases | Corporate Officer/Principal | 01/01/1999 |
Napp Pharmaceuticals Ltd.
Napp Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Corporate Officer/Principal | 02/01/1990 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Alterola Biotech, Inc. (California)
Alterola Biotech, Inc. (California) Chemicals: SpecialtyProcess Industries Manufactures medicament containing chewing gums | Process Industries |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Engages in developing novel treatments targeting diseases | Health Technology |
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets novel therapeutics | Health Technology |
Napp Pharmaceuticals Ltd.
Napp Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Loughborough University
Loughborough University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
Cardiol Therapeutics, Inc.
Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease | Health Technology |
Alinova Biosciences Ltd. | |
Alterola Biotech, Inc.
Alterola Biotech, Inc. Pharmaceuticals: OtherHealth Technology Develops medical cannabis products | Health Technology |
Phytotherapeutix Holdings Ltd. | |
Phytotherapeutix Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national